Concepedia

Natasha S. Clayton

NS

5

Publications

148

Citations

5

H-Index

2016

Active since

Affiliations

Queen Mary University of London(Current)

University of Cambridge

Natasha S. Clayton is an author at Queen Mary University of London specializing in oncology, tumor biology, and tissue development.

ORCID

Top concepts

Publications per year

2016–2023

5

Publications

5

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

Abbie E. Fearon, Edward Carter, Natasha S. Clayton et al. · Cell Reports · 2018 · 64 citations · Full text

Emerging Roles of Fibroblast Growth Factor 10 in Cancer

Natasha S. Clayton, Richard Grose · Frontiers in Genetics · 2018 · 39 citations · Full text

, , +13

Inhibition of Ral GTPases Using a Stapled Peptide Approach

Jemima C. Thomas, Jonathan M. Cooper, Natasha S. Clayton et al. · Journal of Biological Chemistry · 2016 · 23 citations · Full text

Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK

Natasha S. Clayton, Millie Fox, Jose J. Vicenté-Garcia et al. · Journal of Biological Chemistry · 2022 · 11 citations · Full text

Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition

Fabiola González‐Herrera, Natasha S. Clayton, Daniela Guzmán‐Rivera et al. · Frontiers in Immunology · 2023 · 11 citations · Full text

Rows per page

1–5 of 5